ARDSAridis Pharmaceuticals Inc.

About Aridis Pharmaceuticals Inc. (ARDS)

Aridis Pharmaceuticals Inc. (ARDS) is a Biotechnology company headquartered in Los Gatos, CA, United States whose shares trade over-the-counter on the Expert Market tier.

Aridis Pharmaceuticals is a biopharmaceutical company focused on the development of novel, differentiated therapies for infectious diseases. Complementing the clinical stage product pipeline is a disruptive platform technology to discover rare, potent human monoclonal antibodies from patients. Our scientists and leadership team have a proven track record of innovation and successful drug development of therapeutic candidates from early discovery to commercial implementation.

Products and services

Aridis Pharmaceuticals is a biopharmaceutical company developing new pharmaceutical products for human infectious diseases.

ARDS key facts

Ticker symbol

ARDS

Market tier

Expert Market

Sector

Healthcare

Industry

Biotechnology

Headquarters

Los Gatos, CA, United States

Country of incorporation

US

Year of incorporation

2014

Employees

25

Estimated market cap

$5.3K (as of Apr 15, 2025)

Shares outstanding

53,320,892

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Latest filing

8K Report (Dec 16, 2023)

Aridis Pharmaceuticals Inc. leadership

• Vu L Truong — CEO
• Hasan Jafri — CMO
• Patricia Poujaud — Accountant

Explore more: Biotechnology stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with A